Skip to main content
. 2015 Dec 14;5:18001. doi: 10.1038/srep18001

Figure 2. Variations of IL-17 and IL-23 concentration in BP serum from baseline until day 150.

Figure 2

Serum concentrations of IL-17 (a) and IL-23 (b) were measured by ELISA at time of diagnosis, 60 days and 150 days after the inclusion of BP patients. (**P  < 0.01) Abbreviations: D0, day 0; D60, day 60; D150, day 150.